Absci Corp.

Biotechnology • Healthcare • Vancouver, WA, United States • ABSI (NMS)

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.

360 949 1041 18105 SE Mill Plain Boulevard, Vancouver, WA 98683, United States

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Absci Corporation (ABSI) Draws Full Buy Consensus With 150% Upside Potential - Finviz

Finviz • Dec 27

Absci Corporation (ABSI) draws full buy consensus with 150% upside potential - MSN

MSN • Dec 27

2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk - MarketBeat

MarketBeat • Oct 13

ABSI Stock Up on Initiating Dosing in Androgenetic Alopecia Study - Zacks Investment Research

Zacks Investment Research • Dec 5

$ABSI stock is up 14% today. Here's what we see in our data. - Quiver Quantitative

Quiver Quantitative • Dec 4

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Absci Corp had layoffs?

No layoff events have been recorded for Absci Corp in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Absci Corp have?

Absci Corp has approximately 156 employees.

What industry is Absci Corp in?

Absci Corp operates in the Biotechnology industry, within the Healthcare sector.

Is Absci Corp a publicly traded company?

Yes, Absci Corp is publicly traded under the ticker symbol ABSI on the NMS. The company has a market capitalization of approximately $0.54 billion.

Where is Absci Corp headquartered?

Absci Corp is headquartered in Vancouver, WA, United States at 18105 SE Mill Plain Boulevard, Vancouver, WA 98683, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.